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Abstract
Leprosy is a chronic infectious disease influenced by unfavorable hou-
sing and sanitation conditions and number of cohabitants, especially 
in cases of relapses. 
Objective: To evaluate relapsed cases of leprosy during the period 
2001-2014 in a Brazilian capital. 
Methods: This is a cross-sectional study conducted in Teresina, a 
high leprosy endemic city. Association tests (chi-square or Fisher's 
exact test) were used to analyze data. 
Results: Three hundred and six cases were reported; 42.5% were 
registered in Basic Health Units (BHUs) and 57.5%, in Reference Units 
(RUs). There was predominance of multibacillary forms of leprosy. The 
typo of health unit reporting the case was associated with the clinical 
form of the disease (p < 0.01) and the number of affected nerves (p 
< 0.05). Records without specification of the clinical form were more 
frequent in BHUs than in RUs, and the dimorphic form was more 
frequently reported in RUs.
Conclusions: The present data has similarities with other studies, but 
it is believed that underreporting of cases takes place in the studied 
city. Thus, greater attention is necessary to the diagnostic confirmation 
of relapses. Training health professionals on epidemiological surveillan-
ce is fundamental, as well as the appropriate management of relapsed 
cases of leprosy in the context of public health.
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Introduction
Leprosy is a low-pathogenic and highly infectious 
chronic disease caused by Mycobacterium leprae. 
Household environments are the main spaces whe-
re transmission takes place. Unfavorable housing 
and sanitation conditions and high number of co-
inhabitants favor the spread of this disease [1, 2].
The decrease of the number of leprosy cases 
in Brazil in recent decades is associated with the 
introduction of multidrug therapy (MDT) in 1986. 
However, despite technical and scientific advances 
and economic and political changes in the Brazilian 
society, these factors have not detectably affected 
the transmission of leprosy and the control of this 
disease has proven difficult [3]. 
A decrease of 68% has been observed in the 
prevalence rate of leprosy in Brazil, a drop from 4.52 
patients per 10,000 inhabitants in 2003 to 1.42 in 
2013, precisely. Notwithstanding these statistics, 
the epidemiological situation is not homogeneous 
in the country, and different prevalence trends and 
control strategies in each region. The North and 
Northeast regions have the highest transmission risk 
rates, with over 80% of all diagnosed cases [4].
The state of Piauí still has highly endemic areas for 
leprosy. Some cities have considerably high risk of 
transmissibility. In 2014, the detection rate in Piauí 
was 33.74 patients per 100,000 inhabitants, and 
the capital, Teresina, is a typically hyperendemic city 
with 49.73 patients per 100,000 inhabitants and 
the leader in the number of cases reported in the 
state [5, 6].
In this context, the study of indicators of the qua-
lity of leprosy services is essential for evaluating the 
effectiveness of the leprosy control program based 
on the new guidelines of the Ministry of Health 
(MOH). One of the indicators is the proportion of 
relapsed cases reported in the year, since it is still 
difficult for health services to confirm relapses, es-
pecially among paucibacillary cases, due to the need 
to differentiate leprosy reactions. It is noteworthy 
that only in 2016 proportion of relapsed cases was 
included in the list of indicators [7].
Leprosy relapse consists in cases where the pa-
tient was regularly treated with official standardi-
zed regimens and correctly discharged for healing 
and returned afterwards with new clinical signs and 
symptoms of active infectious disease, such as in-
creased number/size of lesions and thickening of 
nerves. Leprosy relapse generally happens in a pe-
riod of more than five years after cure. The indica-
tor consists in identifying municipalities reporting 
relapsed cases for monitoring of therapeutic failure, 
since the increasing number of cases may be related 
to relapses [8, 9].
 Between 2004 and 2009, the worldwide num-
ber of relapsed cases of leprosy stayed relatively 
constant; between 2,000 and 3,000 cases. In Tere-
sina, 56 relapsed cases were diagnosed from 2001 
to 2008, and some nerves were observed to be 
already affected in 18% (n = 10) of these cases 
[10, 9].
Conducting the follow-up of healed or dischar-
ged patients is essential because this makes it pos-
sible to detect relapses, reactions and infections, 
thus providing a reliable support for decision-ma-
king related to the needs of patients. Thus, stu-
dies on leprosy relapse favor the delineation of 
the clinical-epidemiological profile of the affected 
population and contribute to reducing the social 
stigma and especially the physical disabilities that 
affect these patients. Thus, the aim of the present 
study was to evaluate relapsed cases of leprosy in 
the period from 2001 to 2014 in the capital city 
of Piauí.
Methods
Study design
Cross-sectional and analytical study that is part of 
a larger Operational research project entitled: IN-
TEGRAHANS PIAUÍ: integrated approach to clini-
cal, epidemiological (space-time), operational and 
psychosocial aspects of leprosy in Piauí cities with 
high endemicity. 
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Local and Study Period
City  of Teresina, located in the northern side of the 
Northeast region of Brazil. Data were collected in 
April 2015. This city was selected for being hype-
rendemic for leprosy. The city belongs to the cluster 
area 1 (SESAPI, 2014) and is part of the 253 priority 
cities for surveillance of leprosy by the Integrated 
Strategic Action Plan 2011-2015 of the Ministry of 
Health.
Population and Sample
All relapsed cases of leprosy in people living in the 
city of Teresina from 2001 to 2014. This informa-
tion was obtained from the Information System for 
Notifiable Diseases (SINAN) of the state.
Inclusion criteria: case classified in the SINAN 
(at the moment of entry) as relapsed case in the 
period 2001-2014; with Teresina-PI as the city of 
notification.
Exclusion criteria: relapsed case recorded by mis-
diagnosis, duplication or transfer to another city. 
The number of relapsed cases reported during 
the study period was 355. After applying the in-
clusion and exclusion criteria, 306 diagnosed cases 
remained.
Procedures for data collection
Data from the official online database of the Infor-
mation System for Notifiable Diseases (SINAN) of 
the State Department of Health of Piauí (SESAPI) 
were analyzed. The variables selected for analysis 
were: gender, age, race, level of education, occu-
pation, number of lesions, affected nerves, clinical 
form, operational classification, degree of disability 
assessed at the beginning of treatment, bacilloscopy 
in the relapse diagnosis and type of discharge.
Procedures for data analysis
The calculation of the percentage indicator of re-
lapsed leprosy consists in the ratio between the 
number of relapses that took place in the years stu-
died and the number of all cases registered in the 
same year for treatment of leprosy, multiplied by 
100. This reflects the quality of the health service 
from the perspective of monitoring treatment fai-
lure [7]. Categorical variables are presented in pro-
portions. Association tests (chi-square or Fisher's 
exact test) were applied, with 95% of confidence 
interval between the variable "unit of notification", 
i.e., basic health unit (BHU) or secondary/tertiary 
reference unit (RU). The level of significance adop-
ted was p <0.05.
Ethical aspects
The study complied with the formal requirements of 
national and international regulatory standards for 
research involving human beings and was approved 
by the Ethics Committee of the Federal University 
of Piauí under Opinion nº: 1115818.
Results 
Table 1 describes the associations between the per-
centage of relapsed cases at the moment of entry 
in BHUs and in RUs and the variables gender, age, 
level of education and race. 
Table 1.  Association between entries for relapsed 
cases of leprosy in basic health units/refe-
rence units and socio-demographic varia-
bles. Teresina, PI, Brazil, 2016.
Variable
Relapses
BHUs RUs Total p-value 
95% CIn % n % n %
Gender
Male 84 64.6 97 55.1 181 59.2
0.0951
Female 46 35.4 79 44.9 125 40.8
Age
< 15 years 4 3.1 6 3.4 296 96.7
0.5712
≥ 15 years 126 96.9 170 96.6 10 3.3
Schooling
Illiterate 20 15.4 30 17.0 50 16.3
0.0371
Primary 
Education
65 50.0 92 52.3 157 51.3
Secondary 
Education
25 19.2 37 21.0 62 20.3
Higher 
Education
3 2.3 10 5.7 13 4.2
Ignored 17 13.1 7 4.0 24 7.8
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Variable
Relapses
BHUs RUs Total p-value 
95% CIn % n % n %
Ethnicity
White 10 7.7 14 8.0 24 7.8
0.9701
Black 12 9.2 14 8.0 26 8.5
Brown 92 70.8 128 72.7 220 71.9
Yellow, 
Indian or 
ignored
16 12.3 20 11.4 36 11.8
Total 130 42.5 176 57.5 306 100.0
1: Pearson Chi-square test; 2: Fisher's exact test.
Source: Information System for Notifiable Diseases (SINAN/
leprosy). State Department of Health of Piauí (SES/PI), 
2001-2014. BHUs: basic health units; RUs: reference units. 
Figure 1:  Percentage of relapsed cases of leprosy 
according to year of diagnosis, from 
2001 to 2014. Teresina, PI, Brazil.
Figure 2:  Percentage of relapsed cases of leprosy 
in Basic Health Units according to the  
operational classification and the year 
of diagnosis 2001-2014. Teresina, PI, 
Brazil, 2016.
Figure 3:  Percentage of relapsed cases of leprosy 
in Reference Units according to the 
operational classification and the year 
of diagnosis 2001-2014. Teresina, PI, 
Brazil, 2016.
Most relapsed cases (59%, n = 181) were male 
patients aged 45.21 years on average (SD = 17.26, 
minimum 6, maximum 86). Among the patients, 
ten were younger than 15 years with similar distri-
bution in the BHUs and RUs. As for schooling, more 
than 50% of the patients had primary education 
and there was a statistically significant difference 
only between the reporting health units and the 
level of education of patients. Most of the patients 
(71.9%) self-declared to be brown-skinned.
The average relapse rate was 21.9 cases per year, 
with a minimum of 8 cases in 2014 and a maximum 
of 43 in 2008. The highest rate (6.6%) was obser-
ved in 2009, and the lowest in 2002 (1.7%) and in 
2014 (1.9%) (Figure 1).
One hundred and thirty relapsed cases of leprosy 
were reported in BHUs (42.5%) and 176 (57.5%) 
cases in secondary and tertiary RUs. Figures 2 and 
3 show that multibacillary (MB) cases were more 
frequent than paucibacillary (PB) cases in the period 
studied in both, BHUs and RUs. Relapsed cases re-
ported in 2008, 2012, 2013 and 2014 in BHUs were 
exclusively MB, as well as were the cases reported 
in 2014 in RUs.
There was an association between the clinical 
form of the disease (p < 0.01), number of affected 
nerves (p < 0.05) and the type of health unit that 
reported the case. Records where the clinical form 
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was ignored were more frequent in BHUs than in 
RUs, and the record of the dimorphic form was 
more frequent in RUs. The dimorphic form (42.2%; 
n = 129) was more frequent among all relapsed 
cases, followed by the Virchowian form (23.2%; n 
= 71). Absence of record on assessment of affec-
ted nerves was proportionally higher in BHUs. The 
mean number of affected nerves was 0.7 (SD = 1.2; 
minimum 0 and maximum 6).
The prevalence of the MB form in the operatio-
nal classification was observed in both BHUs and 
RUs (> 70%, n = 224). Among patients 93 (30.4%) 
presented some physical impairment at the moment 
of diagnosis and only 85 (27.8%) performed smear 
microscopy, which were mostly positive, reinforcing 
the bacillary persistence. Cure rate was slightly hig-
her than 80% and the number of ignored dischar-
ges reached 22 (7.2%). (Table 2)
Discussion
Several aspects contribute to the occurrence of 
relapses. These may be related to intrinsic factors 
of the bacillus, such as reinfection of the patient 
due to irregular treatment adherence by patients, 
or to extrinsic factors such as difficult distinction 
between leprosy reaction and relapse in health 
services [2, 7].
In 2013, an average of 3,196 relapsed cases were 
reported in a survey conducted in 96 countries, while 
in 2014, 1312 cases were reported, excluding Brazil. 
However, a decreased of more than 100 cases was 
observed in the country between 2013 and 2012 [2, 
11]. Thus, following the global strategy of the World 
Health Organization (WHO), the MOH has adopted 
the assessment of cases in 2016 as an indicator to 
identify municipalities that notify relapsed cases in 
order to monitor treatment failure. It is noteworthy 
that, because this measure has only recently been 
implemented, there are no parameters to guide the 
classification of cases. 
The drop in the number of relapses can be re-
lated to the consistent conduct of health services 
Table 2.  Association between entries for relapsed 
leprosy in basic health units and referen-
ce units and clinical variables. Teresina, PI, 
Brazil.
Variable
Relapses
BHUs RUs Total p-value 
95% CIn % n % n %
Clinical form
Indeterminate 15 11.5 26 14.8 41 13.4
0.000
Tuberculoid 23 17.7 25 14.2 48 15.7
Dimorphic 47 36.2 82 46.6 129 42.2
Virchowian 29 22.3 42 23.9 71 23.2
Ignored 16 12.3 01 0.6 17 5.6
Number of affected nerves
None 23 17.7 55 31.2 78 25.5
0.014≥ 1 20 15.4 30 17.0 50 16.3
Ignored 87 66.9 91( 51.7 178 58.2
Operational classification
Paucibacillary 32 24.6 50 28.4 82 26.8
0.459
Multibacillary 98 75.4 126 71.6 224 73.2
Number of lessions
< 5 69 53.1 95 54.0 164 53.6
0.876
≥ 5 61 46.9 81 46.0 142 46.4
Lelvel of physical disability in the diagnosis
Zero 73 56.2 117 66.5 190 62.1
 0.288
G1 34 26.2 34 19.3 68 22.2
G2 11 8.5 14 8.0 25 8.2
Not evaluated 12 9.2 11 6.2 23 7.5
Bacilloscopy
Positive 21 16.2 31 17.6 52 17.0
0.144
Negative 10 7.7 23 13.1 33 10.8
Not 
performed
16 12.3 31 17.6 47 15.4
Ignored 83 63.8 91 51.7 174 56.9
Type of leave
Healing 101 77.7 144 81.8 245 80.1
0.365
Transference 5 3.8 11 6.2 16 5.2
Death or 
Abandonment
12 9.2 11 6.2 23 7.5
Ignored 12 9.2 10 5.7 22 7.2
1: Pearson Chi-square test.
Source: Information System for Notifiable Diseases (SINAN/
leprosy). State Department of Health of Piauí (SES/PI), 
2001-2014. BHUs: basic health units; RUs: reference units. 
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based on the differential diagnosis between reac-
tion and relapse through association of clinical and 
laboratory tests. At the same time, this drop may 
also reflect the underreporting of cases, hindering 
accurate estimates of the number of relapses.
The findings of this study revealed that the majo-
rity of the 306 patients who entered in basic health 
units and reference units for relapsed leprosy from 
2001 to 2014 were male individuals and adults. Re-
search studies have indicated the males predomi-
nate in new cases and in relapsed cases of leprosy; 
men are between 0.21 and 0.81 times more likely 
to have a relapse when compared to women. This 
may be related to the persistent behavior of low 
search for health services in the case of men [12, 
13, 14, 15, 16]. 
The mean age was 45.21 years. This age is close 
to data found in studies conducted in the North 
(49 years) [17], Midwest (46.3 years) [13] and Nor-
theast of Brazil (42.3 years) [10]. The predominance 
of adults in leprosy relapse cases is also common 
in India and Colombia where the predominant age 
groups are 15-35 years and average of 39 years, 
respectively [14, 18]. An adult is five times more 
likely to experience a relapse than a child, provided 
the other variables are kept the same [12]. 
It was noted that level of education had a signifi-
cant effect on the incidence of relapses. The num-
ber of patients with higher education was greater 
in RUs while and the number of ignored cases was 
greater in BHUs. This shows that people with higher 
levels of education prefer seeking specialized centers 
and that collection of data for characterization of 
patients is frequently ignored in basic health units.
As for ethnic group, the majority of patients 
seeking health services for relapsed leprosy was 
brown-skinned (71.9%). In fact, the majority (71%) 
of people in the Brazilian population declare them-
selves black or brown- skinned, according to the 
last census held in Brazil [19]. A study conducted 
in Mato Grosso presented the brown ethnicity as a 
protective factor against leprosy relapse [13].
Considering the Primary Health Care as the main 
gateway to assistance, it was observed that the 
multibacillary form of leprosy prevails in the cases 
reported each year. This suggests late diagnosis or 
endemism in the exposed population and lack of 
skill from the part of professionals when it comes to 
dealing with this disease. This weakens the service 
and the quality of care offered to people living with 
leprosy [12, 20].
Reference Units (Secondary or Tertiary) are pre-
pared to address cases of difficult diagnosis, clinical 
complications, adverse reactions to treatment, le-
prosy reactions, relapses and need for surgical re-
habilitation or when there is suspicion of multidrug 
therapy failure, as this type of treatment may cause 
drug resistance. Therefore, patients may need to be 
referred for appropriate follow-up [9].
It was found that the diagnosis of relapses oc-
curs predominantly in Reference Units. These en-
vironments have specific criteria favoring the iden-
tification of leprosy for proper management. This 
opposes to the fact [21] that the highest percentage 
of diagnosed relapses was found in BHUs in the 
present study, most of which were confirmed even 
despite the negative result for bacilloscopy. This su-
ggests that the health care network has difficulties 
to accurately diagnose cases of relapse.
The multibacillary form of the disease was pre-
dominant in the present survey. This indicates that 
patients are referred to assistance in serious states 
and that the professionals have difficulty that to 
diagnose leprosy in early stages. In a specialized 
Reference Unit in northern Pará, the multibacillary 
form was present in 96.3% (n = 27) of all patients 
[22]. 
The operational classification has significant in-
fluence on cases of leprosy relapse; the multibacillary 
form is four times more likely to induce a relapse 
than the paucibacillary form [10]. Such information 
becomes even more alarming when considering 
the inconsistencies in the system, since there is no 
congruence between the operational classification, 
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the number of nerves affected and the number of 
injuries that can be related to the permanent and 
continuous education of the professionals involved 
in the care.
With regard to clinical forms, the most frequent 
was the dimorphic, corresponding to 42.2% (n = 
129) of cases identified in BHUs (36.2%) and RUs 
(46.6%), followed by the Virchowian form with 23.2 
% of the relapses. Both are multibacillary forms of 
the disease. The predominance of this form reflec-
ts the preponderance of late diagnosis and, conse-
quently, increased risk of onset of physical disabili-
ties. The same was observed in another study [18]. 
This translates the persistence of the transmission 
chain and reinforces the need for attention from 
the part of professionals to ensure adherence to 
treatment and active search for contacts [9, 18, 22].
It is worth mentioning that the percentage of in-
formation ignored in SINAN is still high, such as the 
type of discharge, which would allow to know the 
outcome of the cases in the health units. Still, the 
majority of the patients were cured, and 22 (7.2%) 
were ignored, that is, the teams did not know the 
actual situation of the patient, hindering the more 
accurate evaluation of relapse-related aspects.
Thus, the recommendation of following-up 
leprosy patients and leprosy complications is relevant 
for comprehensive care. Services that make up the 
leprosy care network must arrange and organize 
the reference and counter-reference system, invest 
in well-trained professionals who are experience in 
the diagnosis of relapses, due to the high preva-
lence of the disease in the capital, establishing the 
flows to ensure proper management of relapses in 
all levels of attention.
Conclusion
The evaluation of relapsed cases of leprosy in Teresi-
na showed that the profile of cases is similar to that 
found in national and international studies on the 
theme. Because this is a study carried out with se-
condary data, the incompleteness and inconsistency 
of some variables represent a limitation, bringing 
some difficulties to the process of data analysis.
It is believed that instances of relapses are under-
-reported in the studied site. Thus, it is imperative to 
pay greater attention to the diagnostic confirmation 
of relapses, especially in multibacillary cases, as this 
is the infecting and disabling form, as well as to 
the neurological and dermatological evaluation of 
all patients for timely diagnosis and prevention of 
physical disabilities. Therefore, the training of health 
professionals is a key to achieving qualified infor-
mation on epidemiological surveillance of relapsed 
cases. This will aid the survey of a most reliable 
profile of the evaluated population.
It is worth noting that the deficiency in the health 
services network in recognizing cases of relapse, 
along with a lack of reliable, complete and accurate 
information, especially the lack of constant evalua-
tion and the lack of information available to recog-
nize the factors associated with relapses, make it 
difficult to plan and strengthen actions in the health 
care network.
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